Chinese patent medicine Zilongjin Tablet has limited effect on controlling the growth of cancer cells and is mainly used for auxiliary treatment. It has a certain auxiliary therapeutic effect on postoperative lung cancer or when lung cancer patients are accompanied by weakness of qi and blood, pain and loss of appetite. In pharmacological test, it has certain inhibitory effect on transplanted hepatocellular carcinoma (Heps), lung cancer (Lewis) and (LA795) in mice. It has the effect of enhancing the delayed hypersensitivity reaction in mice, and can induce activated human lymphocytes to kill tumor cells. It can improve the proliferation ability of T lymphocytes and reduce some of the toxic effects of chemotherapeutic drugs such as cisplatin and cyclophosphamide. Effective therapeutic measures for lung cancer need to be staged in time according to the pathological type of patients. If it is early stage of lung cancer, it needs timely surgical treatment, supplemented with radiotherapy after surgery. In case of advanced stage, radiotherapy, chemotherapy, targeted therapy and other comprehensive treatments are usually adopted to control tumor growth and prolong life. For patients with advanced stage of lung cancer or with poor physique, such as symptoms of fatigue, lack of energy, lack of speech, dizziness, loss of appetite, shortness of breath, spontaneous sweating (involuntary sweating during the daytime, aggravated by sweating when moving a little), pain, etc., they can take Zilongjin tablets under the guidance of doctor, which can improve the symptoms.